Ken Fisher

Ken Fisher Fisher Asset Management

AUM $293B
1-Year Est. Return 28.33%
 

Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+28.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$293B
AUM Growth
+$16.7B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,126
New
Increased
Reduced
Closed

Top Buys

1
+$4.54B
2
+$427M
3
+$280M
4
NVDA icon
NVIDIA
NVDA
+$279M
5
MSFT icon
Microsoft
MSFT
+$222M

Top Sells

1
+$2.04B
2
+$1.57B
3
+$275M
4
ITUB icon
Itaú Unibanco
ITUB
+$249M
5
INTU icon
Intuit
INTU
+$161M

Sector Composition

1 Technology 25.35%
2 Financials 19.13%
3 Healthcare 9.52%
4 Industrials 9.41%
5 Communication Services 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IEUR icon
376
iShares Core MSCI Europe ETF
IEUR
$7.55B
$12.8M ﹤0.01%
179,893
-6,688
AUB icon
377
Atlantic Union Bankshares
AUB
$5.7B
$12.7M ﹤0.01%
360,291
+38
UE icon
378
Urban Edge Properties
UE
$2.62B
$12.6M ﹤0.01%
656,494
-64,881
WSFS icon
379
WSFS Financial
WSFS
$3.57B
$12.6M ﹤0.01%
227,946
+92
CUZ icon
380
Cousins Properties
CUZ
$3.77B
$12.6M ﹤0.01%
486,830
-4,195
CLB icon
381
Core Laboratories
CLB
$864M
$12.4M ﹤0.01%
774,979
-49,600
EW icon
382
Edwards Lifesciences
EW
$44B
$12.4M ﹤0.01%
145,645
-101,775
RNST icon
383
Renasant Corp
RNST
$3.85B
$12.1M ﹤0.01%
344,721
-12,204
SPY icon
384
State Street SPDR S&P 500 ETF Trust
SPY
$698B
$11.8M ﹤0.01%
17,349
+2,410
VRTX icon
385
Vertex Pharmaceuticals
VRTX
$125B
$11.4M ﹤0.01%
25,218
-741
ACA icon
386
Arcosa
ACA
$6.25B
$11.4M ﹤0.01%
107,453
-4,653
IONS icon
387
Ionis Pharmaceuticals
IONS
$13.1B
$11.2M ﹤0.01%
141,615
+135,405
BMY icon
388
Bristol-Myers Squibb
BMY
$124B
$11M ﹤0.01%
204,728
-11,414
SHO icon
389
Sunstone Hotel Investors
SHO
$1.75B
$11M ﹤0.01%
1,234,457
-114,774
KNSA icon
390
Kiniksa Pharmaceuticals
KNSA
$3.44B
$11M ﹤0.01%
267,274
-15,014
ALKS icon
391
Alkermes
ALKS
$5.48B
$10.9M ﹤0.01%
390,493
+67,745
VVX icon
392
V2X
VVX
$2.04B
$10.9M ﹤0.01%
200,016
-13,663
PK icon
393
Park Hotels & Resorts
PK
$2.24B
$10.8M ﹤0.01%
1,028,023
-1,376
HAL icon
394
Halliburton
HAL
$28.4B
$10.7M ﹤0.01%
379,513
-53,364
PAYC icon
395
Paycom
PAYC
$6.87B
$10.7M ﹤0.01%
67,142
-9,870
MICC
396
The Magnum Ice Cream Company N.V.
MICC
$10.3B
$10.5M ﹤0.01%
+661,378
OUT icon
397
Outfront Media
OUT
$4.19B
$10.5M ﹤0.01%
433,833
-18,390
SO icon
398
Southern Company
SO
$105B
$10.4M ﹤0.01%
119,135
-856
CURB
399
Curbline Properties
CURB
$2.76B
$10.4M ﹤0.01%
446,894
-39,763
SCI icon
400
Service Corp International
SCI
$11.1B
$10.2M ﹤0.01%
130,997
-9,866
14 15
16
17 18